Sitagliptin/Metformin Generinobel

Sitagliptin/Metformin Generinobel is a combination oral medication used to manage type 2 diabetes. It combines two active ingredients to help control blood sugar levels effectively. This medication is prescribed alongside diet and exercise for better glycemic control.

Sitagliptin/Metformin Generinobel is used to improve blood sugar control in adults with type 2 diabetes. It combines sitagliptin, a DPP-4 inhibitor, and metformin, a biguanide, to support glucose regulation. This combination therapy is typically prescribed when diet and exercise alone are insufficient. It may also be used alongside other diabetes medications for enhanced effects.

Sitagliptin/Metformin Generinobel helps maintain steady blood sugar levels throughout the day. Users may experience improved energy levels and reduced symptoms of high blood sugar, such as excessive thirst or frequent urination. Some individuals notice better overall well-being with consistent use.

Store Sitagliptin/Metformin Generinobel at room temperature, away from moisture and heat. Keep it in its original packaging and out of reach of children. Avoid crushing or splitting tablets unless advised by a healthcare professional. Report any unusual symptoms to a doctor promptly.

Sitagliptin/Metformin Generinobel may interact with alcohol, increasing the risk of lactic acidosis. Certain medications, such as diuretics or corticosteroids, can affect blood sugar levels when taken with this drug. Always inform your doctor about all medications and supplements you are using.